1999
DOI: 10.1016/s1079-2104(99)70110-1
|View full text |Cite
|
Sign up to set email alerts
|

A retrospective study of the management of oral mucous membrane pemphigoid with dapsone

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
30
0
1

Year Published

2001
2001
2021
2021

Publication Types

Select...
2
2
1

Relationship

0
5

Authors

Journals

citations
Cited by 51 publications
(31 citation statements)
references
References 24 publications
0
30
0
1
Order By: Relevance
“…1 For more severe cases, including those with ocular, laryngeal, pharyngeal, or esophageal involvement; those with more widespread involvement; or for those recalcitrant to previous therapies, systemic antiinflammatory or immunosuppressive medications have been used. 1 Some of these systemic medications include corticosteroids, 5 dapsone, 6,7 cyclophosphamide, 8 mycophenolate mofetil hydrochloride, 9 intravenous immunoglobulin, 10,11 azathioprine sodium, mitomycin C, 5 interferon alfa-2b, 12 and methotrexate. 13 The response of MMP to these treatment modalities has been variable.…”
mentioning
confidence: 99%
“…1 For more severe cases, including those with ocular, laryngeal, pharyngeal, or esophageal involvement; those with more widespread involvement; or for those recalcitrant to previous therapies, systemic antiinflammatory or immunosuppressive medications have been used. 1 Some of these systemic medications include corticosteroids, 5 dapsone, 6,7 cyclophosphamide, 8 mycophenolate mofetil hydrochloride, 9 intravenous immunoglobulin, 10,11 azathioprine sodium, mitomycin C, 5 interferon alfa-2b, 12 and methotrexate. 13 The response of MMP to these treatment modalities has been variable.…”
mentioning
confidence: 99%
“…10,12,13 Immunosuppressive agents such as azathioprine or cyclosphosphamide are often used for their corticosteroid-sparing effects. 11,[14][15][16] Combination therapies can have more adverse effects and mandate careful monitoring. 17,18 Intravenous (IV) immunoglobulin has been successfully used in the treatment of autoimmune and chronic inflammatory disorders, such as idiopathic thrombocytopenic purpura, Kawasaki disease, GuillainBarré syndrome, and dermatomyositis.…”
Section: Studymentioning
confidence: 99%
“…19 Since the first report of its use in a few patients with bullous pemphigoid in 1985, 20 several investigators have reported on its efficacy in the therapy of both bullous pemphigoid and pemphigus vulgaris. 11,[21][22][23][24][25][26][27][28] Our retrospective study describes 20 patients with involvement of the oral cavity who were observed between September 1, 1994, and October 31, 2000. Since topical therapy was ineffective, dapsone therapy was initiated.…”
Section: Studymentioning
confidence: 99%
See 2 more Smart Citations